Exhibiting at SU-54
Vivid Genomics is a precision medicine company dedicated to improving the success of drug development in neurodegenerative disease. Using genomics, machine learning, and biological data, we develop genetic-based tests to identify patient variation that impacts clinical trial outcomes to support drug developers to better design and analyze trials. Our first tests are focused on Alzheimer’s disease; with the information from these tests, pharma companies are empowered to enroll the right patients, improve the probability of clinical trial success, and ultimately lead to the first drugs to slow or cure Alzheimer’s disease.